欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2025, Vol. 30 ›› Issue (8): 0-0.

• 临床药理学 •    下一篇

基于生理药代动力学模型(PBPK)的维生素D3个体化给药方案研究

魏园园1,周旭2,马涛3,唐跃洲1,李琥波4,田晓瑜4,党云洁1   

  1. 1. 河北医科大学药学院
    2. 河北医科大学
    3.
    4. 河北医科大学附属第二医院
  • 收稿日期:2024-09-20 修回日期:2025-02-07 出版日期:2025-08-26 发布日期:2025-08-09
  • 通讯作者: 周旭 E-mail:zxsaso@126.com
  • 基金资助:
    河北省卫生健康委医学科学研究课题;国家自然科学基金面上项目;国家自然科学基金面上项目

Individualized dosage study of Vitamin D3 based on Physiologically-based pharmacokinetic (PBPK) modeling

  • Received:2024-09-20 Revised:2025-02-07 Online:2025-08-26 Published:2025-08-09

摘要: 摘 要: 目的 建立维生素D3(Vd3)的成人生理药代动力学(PBPK)模型,为维生素D(Vd)缺乏人群的临床合理用药提供指导。方法 查阅相关文献和数据库,获得Vd3的理化性质和药动学参数。应用PK-Sim?软件进行Vd3成人全身PBPK模型的构建、优化和预测。以置信区间、拟合优度和倍数误差(FE)为评价指标验证模型预测性能,并根据最终的优化模型对临床常用给药方案的有效性进行评估,同时给出推荐的个体化给药方案。结果 建立的Vd3成人全身PBPK模型,拟合优度R2为0.961接近于1,且AUC0-∞和Cmax的FE值皆在0.5和2以内,这表明所建立的PBPK模型具有良好的数据预测能力。结论 成功构建了口服Vd3的成人PBPK模型,模型对单次口服Vd3具有良好的预测性能。单次口服Vd3(7 500 μg和15000 μg)是改善亚洲成年人Vd不足/缺乏状况的安全有效的剂量方案,治疗前和治疗期间,应定期监测25(OH)D3的水平以实现个体化治疗的最佳效果。

关键词: 维生素D3, PK-Sim?, PBPK, 药代动力学, 拟合优度, 剂量预测

Abstract: Abstract: Objective To establish a Physiologically-based pharmacokinetic (PBPK) modeling for vitamin D3 (Vd3)in adults, thereby recommending appropriate clinical dosages for individuals with vitamin D(Vd) deficiencies. Methods A comprehensive review of relevant literature and databases was conducted to gather the physicochemical properties and pharmacokinetic parameters of Vd3. Subsequently, the PK-Sim? software was utilized to construct, optimize, and predict the whole-body PBPK model of Vd3 in adults. The model's predictive performance was evaluated based on confidence intervals, goodness-of-fit, and fold error. Based on the optimized model, the effectiveness of current clinical dosing regimens was further assessed, and personalized dosage recommendations were provided. Results The goodness-of-fit, R2 of 0.961 is close to 1 and FE values for AUC0-∞ and Cmax between 0.5 and 2 indicating the established adult whole-body PBPK model has excellent predictive capabilities. Conclusion Successfully constructed the adult PBPK model for oral Vd3 supplementation, the model demonstrates good predictive performance for a single oral dose of Vd3. A single oral dose of Vd3 (7 500 μg and 15000 μg) is considered a safe and effective dosing regimen to ameliorate Vd insufficiency/deficiency in Asian adults. Before and during the treatment, regular monitoring of 25(OH)D3 levels should be conducted to achieve the optimal outcome of personalized therapy.

Key words: itamin D3, PK-Sim?, PBPK, pharmacokinetics, goodness of fit, dose prediction